Inflammation is a normal biological response to injury and other insults and invaders to the body. However, in some situations, with chronic or extreme stressors present, an imbalance in the relationship between pro-inflammatory and anti-inflammatory mediators may occur. An unhealthy response may lead to chronic inflammation and create lasting damage.

Palmitoylethanolamide (PEA), is a fatty acid amide that has demonstrated a functional ability to effectively address various inflammatory mechanisms that develop and effect the chronic pain state. Additionally, PEA exhibits a multifaceted immune response due to its unique mechanism of actions that target multiple pathways at different sites, working synergistically to produce therapeutic effects, including clinically validated immune function modulations related to specified endocannabinoid receptors.

Download this white paper and learn about PEA, its biochemistry and mechanism of action, and discover more about the clinical research history leading to today’s findings.